Loading...
Loading...
September 26, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader recently tabbed North Carolina’s Thought Leader Select to assist the company with an upcoming slate of key opinion leader (KOL) initiatives in the area of bacterial infections. The KOL initiatives will support a[...]
Industry Insights from Paul Meade, M.Sc., MPH Social Media has to be the top buzzword of this still-young millennium, and everyone has been jumping on the bandwagon in the last several years (over one-sixth of planet Earth’s population!). We’re way[...]
By Allison Murphy I am proud to say that I joined the Medical Science Liaison Society in its inaugural year of 2012. After spending a decade as an MSL at Eli Lilly, I see multiple benefits of the society for[...]
July 9, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader has chosen Thought Leader Select to perform critical research and advisory work in support of key opinion leader initiatives advancing companion diagnostics for oncology medications. Thought Leader Select, headquartered in Chapel[...]
Thought Leader Select is a proud supporter of the Medical Science Liaison Society, a non-profit organization dedicated to advancing the MSL role in the life sciences industry. The following release announces the organization’s second global event of 2013: On the[...]
The Canadian Business Association of North Carolina (CBA-NC) is pleased to announce the addition of five Triangle-area business leaders, Paul Meade, Geoffrey Sinn, Henry Grzes, David Byerley, and Andrea Carska-Sheppard to its board of directors. CBA-NC is an exchange where[...]
(CHAPEL HILL, NC) Canadian subsidiaries of a pair of top-15 global biopharmaceutical companies have appointed Thought Leader Select as their preferred research and engagement advisor for key opinion leader initiatives in multiple therapeutic areas. Thought Leader Select, headquartered in Chapel Hill,[...]
June 13, 2013 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in gastroenterology with a leading U.S. biopharmaceutical company. The company,[...]
We were inspired by a recent PharmaLive story on Lilly’s new initiative highlighting the key work that medical professionals undertake at the company during all facets and phases of drug discovery and development. The story notes that over 500 physicians,[...]
